Medistim ASA Statistics

Total Valuation

Medistim ASA has a market cap or net worth of NOK 3.52 billion. The enterprise value is 3.37 billion.

Market Cap	3.52B
Enterprise Value	3.37B

Important Dates

The last earnings date was Friday, February 28, 2025.

Earnings Date	Feb 28, 2025
Ex-Dividend Date	Apr 25, 2024

Share Statistics

Medistim ASA has 18.31 million shares outstanding. The number of shares has increased by 0.10% in one year.

Current Share Class	n/a
Shares Outstanding	18.31M
Shares Change (YoY)	+0.10%
Shares Change (QoQ)	+0.27%
Owned by Insiders (%)	9.98%
Owned by Institutions (%)	84.54%
Float	11.40M

Valuation Ratios

The trailing PE ratio is 33.87 and the forward PE ratio is 33.51.

PE Ratio	33.87
Forward PE	33.51
PS Ratio	6.25
PB Ratio	8.05
P/TBV Ratio	9.35
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	32.47
EV / Sales	5.99
EV / EBITDA	22.14
EV / EBIT	25.72
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.00, with a Debt / Equity ratio of 0.06.

Current Ratio	4.00
Quick Ratio	2.50
Debt / Equity	0.06
Debt / EBITDA	0.16
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 24.88% and return on invested capital (ROIC) is 18.68%.

Return on Equity (ROE)	24.88%
Return on Assets (ROA)	15.16%
Return on Invested Capital (ROIC)	18.68%
Return on Capital Employed (ROCE)	28.03%
Revenue Per Employee	3.73M
Profits Per Employee	687,629
Employee Count	151
Asset Turnover	1.04
Inventory Turnover	0.74

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +4.37% in the last 52 weeks. The beta is 0.88, so Medistim ASA's price volatility has been lower than the market average.

Beta (5Y)	0.88
52-Week Price Change	+4.37%
50-Day Moving Average	157.98
200-Day Moving Average	164.07
Relative Strength Index (RSI)	77.38
Average Volume (20 Days)	52,994

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medistim ASA had revenue of NOK 562.60 million and earned 103.83 million in profits. Earnings per share was 5.67.

Revenue	562.60M
Gross Profit	448.92M
Operating Income	131.08M
Pretax Income	134.25M
Net Income	103.83M
EBITDA	152.30M
EBIT	131.08M
Earnings Per Share (EPS)	5.67

Full Income Statement

Balance Sheet

The company has 179.21 million in cash and 25.06 million in debt, giving a net cash position of 154.15 million or 8.42 per share.

Cash & Cash Equivalents	179.21M
Total Debt	25.06M
Net Cash	154.15M
Net Cash Per Share	8.42
Equity (Book Value)	436.61M
Book Value Per Share	23.84
Working Capital	321.76M

Full Balance Sheet

Cash Flow

Operating Cash Flow	141.56M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 79.79%, with operating and profit margins of 23.30% and 18.46%.

Gross Margin	79.79%
Operating Margin	23.30%
Pretax Margin	23.86%
Profit Margin	18.46%
EBITDA Margin	27.07%
EBIT Margin	23.30%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 6.00, which amounts to a dividend yield of 3.13%.

Dividend Per Share	6.00
Dividend Yield	3.13%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.10%
Shareholder Yield	3.03%
Earnings Yield	2.95%
FCF Yield	n/a

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a